An interventional study of RAM-based Nursing Empowerment Program and Routine Care and Educational Booklet in Congenital Heart Disease, Postoperative Care and Child Development, sponsored by Cukurova University. Not yet recruiting at 3 sites in Turkey (Türkiye). Open to participants aged 1 Year to 3 Years. Per ClinicalTrials.gov, last updated 2026-05-12.
Sponsored by Cukurova University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Heart Defects, Congenital with a site in Turkey — 11 open to participants now, 12 under way, none of them phase 3. Heart Defects, Congenital · Turkey.
Among the 32 studies in Heart Defects, Congenital with a site in Turkey, this one is the 4th largest by planned enrollment of the 18 interventional ones that give a count, is one of 5 that started in 2026, is one of 17 with no phase, reaches primary completion later than 8 of the 11 other live ones, and was the 29th registered.
992 studies on the registry are indexed under Heart Defects, Congenital; 252 are open to participants now.
Browse Heart Defects, Congenital studies →11 of the 32 studies in Heart Defects, Congenital with a site in Turkey are open now. Recruiting first, the newest first:
Baskent University · Sites in Turkey
Ages 2 mo–12 mo
Fondation Hôpital Saint-Joseph · Sites in Turkey, Denmark, Egypt and 14 more countries
Ages 1 mo+
Ankara Yildirim Beyazıt University · Sites in Turkey
Ages 16–20
Hacettepe University · Sites in Turkey
Ages 8–55 · Healthy volunteers
Occlutech International AB · Sites in Turkey, Ireland, United Kingdom
Ages 3 mo–80 yrs
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 156 Heart Defects, Congenital studies recruiting now, 69 (44%) set no upper age limit and 79 (51%) stop at 75 or younger; 112 take children under 18; 25 take healthy volunteers.
This study: 1 Year to 3 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is above the median of 60 across 508 interventional studies indexed under Heart Defects, Congenital.
Median enrollment 51 across the 18 interventional studies, 71 across the 14 observational. Of the 15 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 32 have an industry lead sponsor. The 10 most frequent:
Cukurova University is the lead sponsor of 261 studies on the registry; 48 are open to participants now.
Cukurova University has 2 studies filed under Heart Defects, Congenital — fewer than ten, so there is no comparison to draw.
5 of the studies in Heart Defects, Congenital with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05684562Hacettepe UniversityPulmonary Determinants of Cardiorespiratory Fitness in Fontan Patients | 2026-12-25 |
| NCT06823635Fondation Hôpital Saint-JosephAn International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects | 2026-12-31 |
| NCT07564882Baskent UniversityThe Effect of Music and Musical Mobile Interventions on Pain and Physiological Parameters | 2027-04-30 |
| NCT07575451Cukurova UniversityEmpowering Families in Pediatric Cardiovascular Surgery: A RAM-Based Approach | 2027-06-15 |
| NCT07319858Istanbul University - CerrahpasaThe Effect of Using Multifunctional Baby Carrier With Heart Surgery | 2027-08 |
Add all 5 to your calendar (.ics) → With an account.
Among the 32 studies in Heart Defects, Congenital with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this clinical trial is to learn about the effects of a nursing support program designed for families of children aged 1 to 3 years who have undergone heart surgery. This program aims to improve parents' caregiving skills and support the healthy growth of their children.
The primary questions the study aims to answer are:
Does the nursing program positively affect the physical growth of children, such as their height and weight?
Does the program improve children's scores on general development tests (Denver II)?
Do parents' attitudes toward child feeding and their confidence in parenting skills increase?
Researchers will divide participants into two groups:
Experimental Group: Families who participate in the nursing education program and receive an informative booklet.
Control Group: Families who only receive an informative booklet and continue with routine hospital follow-ups.
The researchers will compare these two groups to see if participating in the nursing program leads to better results for the children's development and the families' skills.
Participants will be asked to:
Attend 5 different education and counseling sessions, starting one week before surgery and continuing until the child reaches 1 year of follow-up.
Meet with the researcher at specific intervals (at 1, 2, 3, 6, 9, and 12 months) for one year to monitor the child's development (height, weight, head circumference) and skills.
Complete surveys regarding child feeding attitudes and parenting skills at the 6th and 12th month follow-ups.
Detailed Description
Participants and Randomization Universe: All families of children aged 1-3 years undergoing heart surgery at the specified hospitals during the study period.
Sample Size: Calculated using G*Power 3.1.9.2 (Effect size $f = 0.25$, $\alpha = 0.05$, power $= 0.80$).Randomization: Participants will be assigned to either the Experimental Group or the Control Group using a simple random number table. Homogeneity between groups will be verified via Chi-square and t-tests regarding baseline demographics (age, education, income).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Families of children aged 1-3 who participate in the RAM-based nursing empowerment program
Behavioral: RAM-based Nursing Empowerment Program
Families who receive routine care and the informative booklet
Other: Routine Care and Educational Booklet
RAM-based nursing empowerment program for families of children (ages 1-3) after heart surgery. Includes 5 structured sessions focusing on family empowerment, coping mechanisms, and child development.
Families in the control group will receive routine care and an educational booklet titled "Family Empowerment Booklet After Cardiac Surgery Based on Roy Adaptation Model". The booklet provides information on care processes and coping strategies.
Developmental Screening Test II (Denver II)
A performance-based test designed to screen children from birth to 72 months for developmental delays. It evaluates 125 items across four domains: Personal-social, fine motor-adaptive, language, and gross motor skills. Results are categorized as Normal, Suspected, or Abnormal based on age-standardized performance.
Time frame: At months 1, 2, 3, 6, 9, and 12 after the intervention
Parental Self-Efficacy Scale (1-3 Years)
A 51-item scale measuring parental self-efficacy in seven domains: Emotional Competence, Responsive Sensitivity, Protection, Discipline, Play, Teaching, and Daily Routines/Care. Scores range from 51 to 255; higher scores indicate stronger parental self-efficacy.
Time frame: Month 6 and Month 12 post-intervention
Child Growth Parameters (Anthropometric Z-Scores)
Growth parameters including height, weight, and Body Mass Index (BMI). Standardized Z-scores (Standard Deviation Scores - SDS) will be calculated using WHO Anthro software based on Turkish growth percentiles (Neyzi et al., 2008). Malnutrition is defined as Z-scores below -2 SD.
Time frame: At months 1, 2, 3, 6, 9, and 12 after the intervention
Feeding Process Maternal Attitude Scale (FPMAS)
This 27-item, 5-point Likert-type scale measures maternal attitudes during the feeding process. It includes five sub-dimensions: Negative Mood During Meals, Attitudes Toward Inadequate/Unbalanced Nutrition, Negative Feeding Strategies, Forced Feeding, and Reaction to Others' Opinions. Total scores range from 27 to 135; higher scores indicate more problematic or negative maternal feeding attitudes.
Time frame: Month 6 and Month 12 post-intervention
Plan to share: No — Individual participant data will not be shared to protect the privacy of participants and due to ethical committee restrictions.
Start is estimated for Jun 2026; primary completion for Jun 2027, 12 months later.
Of 208 non-industry interventional studies with no phase under Heart Defects, Congenital, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 12 months is below that.
Counting every sponsor, half of 226 studies reached it within 34 months; a quarter within 17 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.